Related Experiment Video
Updated: May 22, 2026

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting
Published on: January 12, 2018
Implementation of an Aspirin Utilization Program in an Early Pregnancy Access Center
Celia Muoser1,2, Ioanna Katehis3, Hannah Rosenthal4
1Montefiore Medical Center/Albert Einstein College of Medicine, Department of Obstetrics & Gynecology and Women's Health, New York, United States, Bronx.
A multifaceted intervention significantly increased low-dose aspirin (LDA) initiation for preeclampsia prevention in high-risk pregnant individuals. This standardized approach improved LDA utilization rates by identifying, educating, and supporting eligible patients.
Area of Science:
- Obstetrics and Gynecology
- Maternal-Fetal Medicine
- Public Health
Background:
- Low-dose aspirin (LDA) is recommended for preeclampsia prevention but is underutilized.
- Standardized screening, patient education, and healthcare system contact can improve LDA uptake.
Purpose of the Study:
- To evaluate a multifaceted intervention's effectiveness in increasing LDA initiation for preeclampsia prevention at the recommended gestational age.
- To compare LDA utilization rates between an intervention group and a routine prenatal care group.
Main Methods:
- Observational cohort study at a large urban medical center.
- Intervention included standardized screening, aspirin prescribing with education, and follow-up outreach.
- Primary outcome: proportion of eligible patients initiating aspirin by 16 weeks gestation.
Main Results:
- The intervention group showed significantly higher LDA initiation by 16 weeks (70.7% vs. 38.6%) and continuation at 24 weeks (74.7% vs. 43.8%).
- Both groups had high prevalence of hypertensive disorders of pregnancy (HDP).
- Patients in both cohorts were predominantly Black or Hispanic with public insurance.
Conclusions:
- A standardized, multifaceted approach to identify, educate, and support at-risk patients increases LDA utilization for preeclampsia prevention.
- Obstetric providers can implement similar strategies to bridge the quality gap in LDA use.
More Related Videos
Related Concept Videos
Intrauterine Drug Delivery Systems
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...

